BCNU-CDDP Continuous Infusion Chemotherapy in Recurrent Oligodendroglioma
Journal of Korean Neurosurgical Society
; : 540-543, 1996.
Article
in Ko
| WPRIM
| ID: wpr-168986
Responsible library:
WPRO
ABSTRACT
Eight patients with recurrent oligodendroglioma were treated with 1.3-bis(2-chloroethyl) nitrosourea(BCNU) and CDD continuous infusion chemotherapy. They were 5 with benign oligodendrogliomas and 3 with anaplastic oligodendrogliomas. All the recurrent tumors had been treated with surgery and radiotherapy. Four patients had already received chemotherapy with ACNU. Seven of them showed response to continuous infusion chemotherapy. The time from the response to progression was 15 to 67 weeks. No severe complication of the chemotherapy was found. In conclusion, BCNU-CDDP continuous infusion chemotherapy is an effective treatment modality in recurrent oligodendrogliomas.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Oligodendroglioma
/
Radiotherapy
/
Carmustine
/
Nimustine
/
Drug Therapy
Limits:
Humans
Language:
Ko
Journal:
Journal of Korean Neurosurgical Society
Year:
1996
Type:
Article